{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:22:39Z","timestamp":1791976959410,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81911530169"],"award-info":[{"award-number":["81911530169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903088"],"award-info":[{"award-number":["81903088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670180"],"award-info":[{"award-number":["81670180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.canlet.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T02:35:39Z","timestamp":1616466939000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Emerging insights into origin and pathobiology of primary central nervous system lymphoma"],"prefix":"10.1016","volume":"509","author":[{"given":"Hua","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-4616","authenticated-orcid":false,"given":"Bozena","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004010050876","article-title":"Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system","volume":"96","author":"Deckert-Schl\u00fcter","year":"1998","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib2","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/foc.2006.21.5.16","article-title":"Primary central nervous system lymphoma: presentation, diagnosis and staging","volume":"21","author":"Eichler","year":"2006","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00454901","article-title":"Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme","volume":"86","author":"Aho","year":"1993","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/neuonc\/nop053","article-title":"Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort","volume":"12","author":"Kiewe","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.02.025_bib5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3389\/fimmu.2019.01941","article-title":"Immune microenvironment of brain metastases-are microglia and other brain macrophages little helpers?","volume":"10","author":"You","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib6","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.7150\/thno.40783","article-title":"Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions","volume":"10","author":"You","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1442164","article-title":"Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system","volume":"7","author":"Nam","year":"2018","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/his.12706","article-title":"Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart","volume":"67","author":"Chang","year":"2015","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.canlet.2021.02.025_bib9","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/ijc.25236","article-title":"Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells","volume":"127","author":"Venetz","year":"2010","journal-title":"Int. J. Canc."},{"issue":"12","key":"10.1016\/j.canlet.2021.02.025_bib10","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1002\/jcp.29790","article-title":"Advances and challenges in the treatment of primary central nervous system lymphoma","volume":"235","author":"Yang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/annonc\/mdv076","article-title":"First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)\u2014a systematic review and individual patient data meta-analysis","volume":"26","author":"Kasenda","year":"2015","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2021.02.025_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1200\/JCO.18.00306","article-title":"Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 Years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase II PRECIS study","volume":"37","author":"Houillier","year":"2019","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.canlet.2021.02.025_bib13","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Soci\u00e9t\u00e9 fran\u00e7aise de Greffe de Mo\u00eblle Osseuse-Th\u00e9rapie cellulaire","volume":"26","author":"Soussain","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2021.02.025_bib14","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"Ferreri","year":"2017","journal-title":"The Lancet Haematol."},{"issue":"7767","key":"10.1016\/j.canlet.2021.02.025_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","article-title":"Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid","volume":"572","author":"Ahn","year":"2019","journal-title":"Nature"},{"issue":"7560","key":"10.1016\/j.canlet.2021.02.025_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.leu.2405019","article-title":"Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell","volume":"22","author":"Montesinos-Rongen","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.canlet.2021.02.025_bib18","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65526-5","article-title":"Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment","volume":"155","author":"Montesinos-Rongen","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V94.5.1738","article-title":"V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity","volume":"94","author":"Thompsett","year":"1999","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.canlet.2021.02.025_bib20","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","article-title":"Gene expression and angiotropism in primary CNS lymphoma","volume":"107","author":"Rubenstein","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2021.02.025_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"7502","key":"10.1016\/j.canlet.2021.02.025_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal centre by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2021.02.025_bib23","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.4049\/jimmunol.158.11.5155","article-title":"Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts","volume":"158","author":"Oprea","year":"1997","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.canlet.2021.02.025_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni.2428","article-title":"The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry","volume":"13","author":"Dominguez-Sola","year":"2012","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2021.02.025_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.3154","article-title":"Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells","volume":"16","author":"Shi","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","article-title":"XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation","volume":"21","author":"Shaffer","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni.3349","article-title":"Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation","volume":"17","author":"Minnich","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","article-title":"Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4","volume":"38","author":"Ochiai","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.celrep.2019.06.029","article-title":"MTA2\/NuRD regulates B cell development and cooperates with OCA-B in controlling the pre-B to immature B cell transition","volume":"28","author":"Lu","year":"2019","journal-title":"Cell Rep."},{"issue":"27","key":"10.1016\/j.canlet.2021.02.025_bib33","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.0903854106","article-title":"BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma","volume":"106","author":"Saito","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.canlet.2021.02.025_bib34","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.1401849","article-title":"IgH chain class switch recombination: mechanism and regulation","volume":"193","author":"Stavnezer","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2004.11.038","article-title":"VH gene analysis of primary CNS lymphomas","volume":"228","author":"Pels","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1750-3639.2003.tb00483.x","article-title":"Molecular characterization of BCL6 breakpoints in primary diffuse large B cell lymphomas of the central nervous system identifies GAPD as novel translocation partner","volume":"13","author":"Montesinos-Rongen","year":"2003","journal-title":"Brain Pathol."},{"issue":"8","key":"10.1016\/j.canlet.2021.02.025_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.jnen.0000229988.48042.ae","article-title":"Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination","volume":"65","author":"Schwindt","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5134","key":"10.1016\/j.canlet.2021.02.025_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.8235596","article-title":"Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma","volume":"262","author":"Ye","year":"1993","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.canlet.2021.02.025_bib39","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B cell lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib40","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V83.7.1757.1757","article-title":"Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma","volume":"83","author":"Lo Coco","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/neuonc\/nov046","article-title":"Prognostic impact of B cell lymphoma 6 in primary CNS lymphoma","volume":"17","author":"Kreher","year":"2015","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","article-title":"Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells","volume":"19","author":"Shapiro-Shelef","year":"2003","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/NEN.0b013e31817dd02d","article-title":"Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma","volume":"67","author":"Courts","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"19","key":"10.1016\/j.canlet.2021.02.025_bib44","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1158\/1078-0432.CCR-12-0845","article-title":"Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas","volume":"18","author":"Gonzalez-Aguilar","year":"2012","journal-title":"Clin. Canc. Res."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib45","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-05-1465","article-title":"Primary diffuse large B cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation","volume":"103","author":"Montesinos-Rongen","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canlet.2021.02.025_bib46","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)62487-X","article-title":"Absence of immunoglobulin class switch in primary lymphomas of the central nervous system","volume":"166","author":"Montesinos-Rongen","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.canlet.2021.02.025_bib47","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"17","key":"10.1016\/j.canlet.2021.02.025_bib48","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin. Canc. Res. : Off. J. Am. Assoc. Canc. Res."},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib51","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3109\/10428194.2014.979413","article-title":"Primary diffuse large B cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations","volume":"56","author":"Yamada","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Adv."},{"issue":"44","key":"10.1016\/j.canlet.2021.02.025_bib53","doi-asserted-by":"crossref","first-page":"27471","DOI":"10.18632\/oncotarget.25463","article-title":"Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma","volume":"9","author":"Takashima","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.canlet.2021.02.025_bib54","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/leu.2009.120","article-title":"Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma","volume":"23","author":"Schwindt","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-4608(02)00799-9","article-title":"CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients","volume":"142","author":"Gonzalez-Gomez","year":"2003","journal-title":"Canc. Genet. Cytogenet."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2141.2004.05109.x","article-title":"Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas","volume":"126","author":"Ferreri","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2021.02.025_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/1471-2407-9-455","article-title":"Array-based DNA methylation profiling of primary lymphomas of the central nervous system","volume":"9","author":"Richter","year":"2009","journal-title":"BMC Canc."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/gcc.22687","article-title":"Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B cell lymphomas","volume":"58","author":"Vogt","year":"2019","journal-title":"Gene Chromosome Canc."},{"issue":"10","key":"10.1016\/j.canlet.2021.02.025_bib59","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B cell lymphomas","volume":"13","author":"Fischer","year":"2011","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1006234115968","article-title":"A new xenograft model of primary central nervous system lymphoma","volume":"43","author":"Saini","year":"1999","journal-title":"J. Neuro-oncol."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1215\/15228517-2008-119","article-title":"Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma","volume":"11","author":"Jahnke","year":"2009","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2021.02.025_bib62","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1158\/1078-0432.CCR-06-2379","article-title":"Characterization and magnetic resonance imaging of a rat model of human B cell central nervous system lymphoma","volume":"13","author":"Soussain","year":"2007","journal-title":"Clin. Canc. Res.: Off. J. Am. Assoc. Canc. Res."},{"issue":"6","key":"10.1016\/j.canlet.2021.02.025_bib63","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-08-2054","article-title":"Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model","volume":"15","author":"Kadoch","year":"2009","journal-title":"Clin. Canc. Res. : Off. J. Am. Assoc. Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2013.07.030","article-title":"CD19 target-engineered T-cells accumulate at tumor lesions in human B cell lymphoma xenograft mouse models","volume":"438","author":"Tsukahara","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2021.02.025_bib65","first-page":"763","article-title":"Selective central nervous system tropism of primary central nervous system lymphoma","volume":"3","author":"Jiang","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib66","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2002-05-1576","article-title":"Expression of B cell -attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma","volume":"101","author":"Smith","year":"2003","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.canlet.2021.02.025_bib67","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1158\/0008-5472.CAN-08-1329","article-title":"Utilization of pathway signatures to reveal distinct types of B lymphoma in the E\u03bc-myc model and human diffuse large B-cell lymphoma","volume":"68","author":"Mori","year":"2008","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.02.025_bib68","doi-asserted-by":"crossref","first-page":"701704","DOI":"10.1155\/2012\/701704","article-title":"Murine models of B-cell lymphomas: promising tools for designing cancer therapies","volume":"2012","author":"Donnou","year":"2012","journal-title":"Adv. Hematol."},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and characterization of BALB\/c lymphoma lines with B cell properties","volume":"122","author":"Kim","year":"1979","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2021.02.025_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2249.2011.04416.x","article-title":"Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics","volume":"165","author":"Donnou","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-9966-32-18","article-title":"Lymphoma B cell responsiveness to CpG-DNA depends on the tumor microenvironment","volume":"32","author":"Ben Abdelwahed","year":"2013","journal-title":"J. Exp. Clin. Canc. Res. : CR (Clim. Res.)"},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib72","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1167\/iovs.12-10316","article-title":"Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B cell lymphomas","volume":"54","author":"Ben Abdelwahed","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.canlet.2021.02.025_bib73","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4049\/jimmunol.137.7.2162","article-title":"Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas","volume":"137","author":"Mizuguchi","year":"1986","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.147.4.1267","article-title":"Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors","volume":"147","author":"Mathieson","year":"1978","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.canlet.2021.02.025_bib75","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/NEN.0b013e31828b7a98","article-title":"Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma","volume":"72","author":"Montesinos-Rongen","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cyto.b.21403","article-title":"Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B cell lymphoma of the central nervous system","volume":"94","author":"Debliquis","year":"2018","journal-title":"Cytometry B Clin. Cytometry"},{"key":"10.1016\/j.canlet.2021.02.025_bib77","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2021.02.025_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hon.2489","article-title":"The use of droplet digital PCR in liquid biopsies: a highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid","volume":"36","author":"Hiemcke-Jiwa","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2021.02.025_bib79","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/bjh.15674","article-title":"MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma","volume":"185","author":"Hiemcke-Jiwa","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2021.02.025_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12885-019-5394-x","article-title":"Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas","volume":"19","author":"Hickmann","year":"2019","journal-title":"BMC Canc."},{"issue":"29","key":"10.1016\/j.canlet.2021.02.025_bib81","doi-asserted-by":"crossref","first-page":"48157","DOI":"10.18632\/oncotarget.18325","article-title":"Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma","volume":"8","author":"Fontanilles","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.canlet.2021.02.025_bib82","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-09-308684","article-title":"Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B cell lymphoma of the central nervous system","volume":"117","author":"Baraniskin","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.02.025_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2018.11.005","article-title":"Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease","volume":"75","author":"Pouzoulet","year":"2019","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.canlet.2021.02.025_bib85","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/IR:23:2-3:147","article-title":"Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase","volume":"23","author":"Khan","year":"2001","journal-title":"Immunol. Res."},{"issue":"29","key":"10.1016\/j.canlet.2021.02.025_bib86","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"suppl 4","key":"10.1016\/j.canlet.2021.02.025_bib87","first-page":"153","article-title":"The BTK Inhibitor PCI-32765 is highly active and well tolerated in patients (pts) with relapsed\/refractory B cell malignancies: final Results from a Phase 1 Study","volume":"22","author":"Advani","year":"2011","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2021.02.025_bib88","doi-asserted-by":"crossref","first-page":"CNS51","DOI":"10.2217\/cns-2019-0022","article-title":"Ibrutinib in primary central nervous system diffuse large B-cell lymphoma","volume":"9","author":"Low","year":"2020","journal-title":"CNS Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:52:58Z","timestamp":1778683978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352100104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":88,"alternative-id":["S030438352100104X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.02.025","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging insights into origin and pathobiology of primary central nervous system lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}